<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
  <title>PeptideX: Legal status changes</title>
  <link>https://peptidex.ai/alerts</link>
  <description>FDA and HHS status changes for peptides, each with a primary source. Education only.</description>
  <item>
    <title>HHS proposes 503A enforcement discretion for six peptides</title>
    <link>https://peptidex.ai/alerts/2026-10-30-hhs-503a-peptides</link>
    <guid>https://peptidex.ai/alerts/2026-10-30-hhs-503a-peptides</guid>
    <pubDate>Fri, 30 Oct 2026 12:00:00 GMT</pubDate>
    <description>A proposed HHS policy (Federal Register 2026-22192) names BPC-157, TB-500, epitalon, KPV, MOTS-c and semax for 503A compounding enforcement discretion. It is proposed, not final, and is not FDA approval.</description>
  </item>
</channel>
</rss>
